AEterna Zentaris (AEZS)
(Delayed Data from NSDQ)
$5.35 USD
-0.05 (-0.93%)
Updated Jul 26, 2024 02:51 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
AEterna Zentaris Inc. [AEZS]
Reports for Purchase
Showing records 101 - 120 ( 168 total )
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
PHASE 3 PERIFOSINE COLORECTAL TRIAL WILL CONTINUE TO COMPLETION
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Top-Line Results From Phase 3 AEZS-130 Study Adds Value To Pipeline
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Top-Line Results From Phase 3 AEZS-130 Study Adds Value To Pipeline
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
2Q11 UPDATE - SOLOREL AND PERIFOSINE APPROACH FINISH LINE
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
2Q11 UPDATE - SOLOREL AND PERIFOSINE APPROACH FINISH LINE
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
PHASE 3 PERIFOSINE COLORECTAL TRIAL PROCEEDING TO FINAL ANALYSIS
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
SOLOREL AND PERIFOSINE APPROACH FINISH LINE - MULTIPLE WAYS TO WIN
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
SOLOREL AND PERIFOSINE APPROACH FINISH LINE - MULTIPLE WAYS TO WIN
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
PERIFOSINE PARTNERSHIP STRUCK IN JAPAN - COLORECTAL DATA BY YE11
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Secures Japanese Out-Licensing Deal for Perifosine With Yakult Honsha
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R